Return On Equity of Rein Therapeutics, Inc. from 31 Mar 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Rein Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2018 to 30 Sep 2025.
  • Rein Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -119%, a 292% decline year-over-year.
  • Rein Therapeutics, Inc. annual Return On Equity for 2024 was -74%, a 60% decline from 2023.
  • Rein Therapeutics, Inc. annual Return On Equity for 2023 was -46%, a 55% increase from 2022.
  • Rein Therapeutics, Inc. annual Return On Equity for 2022 was -103%, a 108% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Rein Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -119% -88% -292% 01 Jul 2025 30 Sep 2025
Q2 2025 -96% -62% -186% 01 Apr 2025 30 Jun 2025
Q1 2025 -82% -48% -141% 01 Jan 2025 31 Mar 2025
Q4 2024 -74% -27% -60% 01 Oct 2024 31 Dec 2024
Q3 2024 -30% +61% +67% 01 Jul 2024 30 Sep 2024
Q2 2024 -33% +69% +67% 01 Apr 2024 30 Jun 2024
Q1 2024 -34% +79% +70% 01 Jan 2024 31 Mar 2024
Q4 2023 -46% +57% +55% 01 Oct 2023 31 Dec 2023
Q3 2023 -91% -0.89% -0.99% 01 Jul 2023 30 Sep 2023
Q2 2023 -102% -27% -36% 01 Apr 2023 30 Jun 2023
Q1 2023 -113% -53% -90% 01 Jan 2023 31 Mar 2023
Q4 2022 -103% -54% -108% 01 Oct 2022 31 Dec 2022
Q3 2022 -90% -36% -67% 01 Jul 2022 30 Sep 2022
Q2 2022 -75% -12% -18% 01 Apr 2022 30 Jun 2022
Q1 2022 -59% +24% +29% 01 Jan 2022 31 Mar 2022
Q4 2021 -49% +116% +70% 01 Oct 2021 31 Dec 2021
Q3 2021 -54% +116% +68% 01 Jul 2021 30 Sep 2021
Q2 2021 -64% +96% +60% 01 Apr 2021 30 Jun 2021
Q1 2021 -83% +64% +44% 01 Jan 2021 31 Mar 2021
Q4 2020 -165% -21% -15% 01 Oct 2020 31 Dec 2020
Q3 2020 -170% -34% -24% 01 Jul 2020 30 Sep 2020
Q2 2020 -160% -30% -23% 01 Apr 2020 30 Jun 2020
Q1 2020 -147% -11% -7.7% 01 Jan 2020 31 Mar 2020
Q4 2019 -144% -38% -36% 01 Oct 2019 31 Dec 2019
Q3 2019 -137% -52% -61% 01 Jul 2019 30 Sep 2019
Q2 2019 -130% -62% -90% 01 Apr 2019 30 Jun 2019
Q1 2019 -136% +329% +71% 01 Jan 2019 31 Mar 2019
Q4 2018 -106% 01 Oct 2018 31 Dec 2018
Q3 2018 -85% 01 Jul 2018 30 Sep 2018
Q2 2018 -69% 01 Apr 2018 30 Jun 2018
Q1 2018 -466% 01 Jan 2018 31 Mar 2018

Rein Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -74% -27% -60% 01 Jan 2024 31 Dec 2024
2023 -46% +57% +55% 01 Jan 2023 31 Dec 2023
2022 -103% -54% -108% 01 Jan 2022 31 Dec 2022
2021 -49% +165% +77% 01 Jan 2021 31 Dec 2021
2020 -214% -70% -49% 01 Jan 2020 31 Dec 2020
2019 -144% -38% -36% 01 Jan 2019 31 Dec 2019
2018 -106% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.